AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 22341702
Drug: Mycophenolate mofetil
RxNorm normalized name: Mycophenolate Mofetil
DrugBank: Mycophenolate mofetil (DB00688)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Mycophenolate mofetil (MMF) with low dose of cyclosporine (C(0): 100 to 150 ng/ml)
Trial: 21387802
Drug: Transcranial magnetic
RxNorm normalized name: transcranial magnetic stimulator
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transcranial magnetic stimulation (TMS) combined with pharmacotherapy
Trial: 21387802
Drug: Standalone pharmacotherapy
RxNorm normalized name: sandalore
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standalone pharmacotherapy
Trial: 15802964
Drug: IFN-alpha and
RxNorm normalized name: IFN .ALPHA.-1B
DrugBank: Interferon alfa-1b (DB18522)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IFN-alpha and ribavirin treatment
Trial: 7486099
Drug: Intravenous fentanyl
RxNorm normalized name: Fentanyl
DrugBank: Fentanyl (DB00813)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intravenous fentanyl (IV‐F)
Trial: 30922713
Drug: Active tDCS
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active tDCS (twice-daily 20-min sessions for 5 days)
Trial: 30027479
Drug: New mint-flavored
RxNorm normalized name: nicotine
DrugBank: Nicotine (DB00184)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: New mint-flavored nicotine gum (4 mg)
Trial: 30027479
Drug: Original flavor
RxNorm normalized name: Rest Easy Night Time Original Flavor
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Original flavor sugar-free nicotine gum (2 mg)
Trial: 30027479
Drug: Original flavor
RxNorm normalized name: Rest Easy Night Time Original Flavor
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Original flavor sugar-free nicotine gum (4 mg)
Trial: 27402599
Drug: Nicotine (7mg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nicotine (7mg nicotine patch and placebo capsule)
Trial: 27402599
Drug: Methylphenidate (placebo
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methylphenidate (placebo patch and 40mg methylphenidate capsule)
Trial: 27402599
Drug: Placebo (placebo
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (placebo patch and capsule)
Trial: 25175269
Drug: Diquafosol 3.0%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diquafosol 3.0% ophthalmic solution, 1 drop, 6 times daily for 4 weeks before surgery
Trial: 25175269
Drug: Artificial tears,
RxNorm normalized name: Artificial Tears, ophthalmic ointment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Artificial tears, 6 times daily for 4 weeks before surgery
Trial: 15163089
Drug: Thalidomide (24
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thalidomide (24 mg/kg/day orally) for 1 month
Trial: 2468266
Drug: Intravesical instillation
RxNorm normalized name: ADSTILADRIN Suspension for Intravesical Instillation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravesical instillation chemotherapy of anticancer agents (group B)
Trial: 2468266
Drug: Bladder instillation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bladder instillation chemotherapy of anticancer agents with OK‐432 intradermal injection (group A)
Trial: 31854069
Drug: PEth ≥50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PEth ≥50 ng/mL
Trial: 29304731
Drug: Volixibat (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Volixibat (0.5 mg, 1 mg, 5 mg or 10 mg)
Trial: 29911849
Drug: 1% Diclofenac
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1% Diclofenac Gel
Trial: 19016257
Drug: Antipsychotic therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antipsychotic therapy in schizophrenic women
Trial: 19016257
Drug: Antipsychotic therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antipsychotic therapy in schizophrenic men
Trial: 16522907
Drug: Conjugated linoleic
RxNorm normalized name: CONJUGATED LINOLEIC ACID
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conjugated linoleic acid (CLA) supplementation (3.4 g/d)
Trial: 11109978
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of estradiol 50 mg and testosterone 100 mg
Trial: 1660011
Drug: Interferon (IFN)
RxNorm normalized name: Interferon Gamma
DrugBank: Interferon Gamma (DB15753)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interferon (IFN) treatment, 1.5 x 10(6) IU subcutaneously three times for the first week followed by 3 x 10(6) IU three times weekly for a further 6 weeks.
Trial: 1660011
Drug: Placebo treatment,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo treatment, matching placebo injections.
Trial: 6175136
Drug: Hydrocortisone cream
RxNorm normalized name: Hydrocortisone Cream
DrugBank: Hydrocortisone succinate (DB14545)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Hydrocortisone cream 1% (50 micrograms)
Trial: 6175136
Drug: Unguentum cetacei
RxNorm normalized name: salicylic acid
DrugBank: Salicylic acid (DB00936)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Unguentum cetacei simplex (cold cream) (50 micrograms)
Trial: 6175136
Drug: Halcinonide cream
RxNorm normalized name: Halcinonide Cream
DrugBank: Halcinonide (DB06786)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Halcinonide cream base (rubbing)
Trial: 17074108
Drug: Tegaserod 6
RxNorm normalized name: tegaserod 6 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tegaserod 6 mg twice daily for 4 weeks
Trial: 15001263
Drug: RT preceded
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RT preceded by chemotherapy (vincristine, etoposide, carboplatin, cyclophosphamide)
Trial: 9216554
Drug: Creatine supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Creatine supplementation (25 g/day)
Trial: 8091242
Drug: Single-agent chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single-agent chemotherapy with drugs like 5-fluorouracil (5-FU), mitomycin, doxorubicin, and cisplatin
Trial: 8091242
Drug: Single agents
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single agents (5-FU and mitomycin)
Trial: 8091242
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of 5-FU with radiation therapy
Trial: 29284448
Drug: Experience Sampling
RxNorm normalized name: gabapentin
DrugBank: Gabapentin (DB00996)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Experience Sampling Method Intervention (ESM-I) consisting of six weeks of ESM combined with weekly feedback regarding the individual's positive affective experiences
Trial: 18485172
Drug: 1000 micrograms
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1000 micrograms of self-administered vaginal misoprostol
Trial: 12930165
Drug: Creatine supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Creatine supplementation (0.3 g Cr.kg(‐1) body mass for 5 days, followed by 2.25 g Cr for 9 days)
Trial: 1545849
Drug: Erythropoietin (36
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Erythropoietin (36 units per kilogram of body weight three times weekly)
Trial: 1545849
Drug: Erythropoietin (18
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Erythropoietin (18 units per kilogram three times weekly)
Trial: 31965179
Drug: l-Leucine (192
FDA approved: no
EMA approved: no
PMDA approved: no
Description: l-Leucine (192 mg/kg body mass) administered daily for 10 weeks
Trial: 2145645
Drug: Intravenous colchicine
RxNorm normalized name: Colchicine
DrugBank: Colchicine (DB01394)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous colchicine
Trial: 591936
Drug: Marijuana extract
RxNorm normalized name: marijuana pollen extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Marijuana extract calibrated to 0.3 mg/kg delta‐9‐tetrahydrocannabinol
Trial: 25736132
Drug: Laparoscopic assisted
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Laparoscopic assisted rectal cancer resection using ENDO RLC general endoscopic linear cutter and single-use loading unit and circular staplers from REACH medical equipment co.LTD
Trial: 23608971
Drug: Postoperative chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Postoperative chemotherapy initiation
Trial: 21762269
Drug: Bismuth-containing quadruple
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bismuth-containing quadruple therapy for 14 days (pantoprazole 20 mg, tetracycline 500 mg, metronidazole 500 mg, bismuth subcitrate 240 mg b.i.d.)
Trial: 21762269
Drug: Bismuth-containing quadruple
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bismuth-containing quadruple therapy for 10 days (pantoprazole 20 mg, tetracycline 500 mg, metronidazole 500 mg, bismuth subcitrate 240 mg b.i.d.)
Trial: 17767071
Drug: Tidal volume
RxNorm normalized name: VOLUME EXPANDERS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tidal volume of 4 mL/kg
Trial: 17767071
Drug: Tidal volume
RxNorm normalized name: VOLUME EXPANDERS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tidal volume of 6-8 mL/kg
Trial: 15383198
Drug: Quetiapine (median
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quetiapine (median dosage, 200 mg/day)
Trial: 15383198
Drug: Risperidone (median
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Risperidone (median dosage, 3 mg/day)
Trial: 8165628
Drug: 2 g
RxNorm normalized name: Molds 2 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 g dried ginger
Trial: 2901018
Drug: Placebo (hypertonic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (hypertonic saline infusion of 1200 ml of 2.5% NaCl)
Trial: 26546403
Drug: 40 mg
RxNorm normalized name: rutin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg lidocaine (Group L)
Trial: 26546403
Drug: 300 mg
RxNorm normalized name: rutin 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 300 mg MgSO4 (Group M)
Trial: 26546403
Drug: 300 mg
RxNorm normalized name: rutin 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 300 mg MgSO4 plus 40 mg lidocaine (Group M+L)
Trial: 15754197
Drug: Ampicillin-sulbactam prophylaxis
RxNorm normalized name: ampicillin / sulbactam
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ampicillin-sulbactam prophylaxis (3 g every 6 h for 3 days) plus standard treatment
Trial: 1919626
Drug: Tamoxifen (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tamoxifen (40 mg daily for 2 years)
Trial: 29878650
Drug: Magnesium sulphate
RxNorm normalized name: Magnesium sulphate
DrugBank: Magnesium (DB14513)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Magnesium sulphate infusion continued for 24 hours postpartum
Trial: 29878650
Drug: No magnesium
RxNorm normalized name: DPBS 1X, NO CALCIUM, NO MAGNESIUM
DrugBank: Nitric Oxide (DB00435)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: No magnesium sulphate infusion (stopped immediately after delivery)
Trial: 25187049
Drug: Relaxation Response
RxNorm normalized name: Besponsa
DrugBank: Inotuzumab ozogamicin (DB05889)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Relaxation Response (RR) daily practice
Trial: 17347862
Drug: Three sessions
RxNorm normalized name: three-lobe sage extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Three sessions of constant low-energy treatment (0.08 mJ/mm(2); 1000 impulses) without local anesthesia
Trial: 14608267
Drug: Fructo-oligosaccharides (FOS)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fructo-oligosaccharides (FOS) and Lactobacillus sporogenes preparation
Trial: 1422689
Drug: Combined therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined therapy (orchiectomy + radiotherapy)
Trial: 25222702
Drug: Hormone therapy
RxNorm normalized name: INVESTIGATIONAL HORMONE THERAPY/REPLACEMENT,OTHER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hormone therapy (HT) with sequential 17β-estradiol plus oral progesterone
Trial: 22769858
Drug: Pre-treatment group
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pre-treatment group (FNB with 0.4 mL/kg 0.375% bupivacaine plus 1:200,000 epinephrine after spinal anesthesia but before the operation)
Trial: 22769858
Drug: Post-treatment group
RxNorm normalized name: hydrocortisone
DrugBank: Hydrocortisone succinate (DB14545)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Post-treatment group (FNB with 0.4 mL/kg 0.375% bupivacaine plus 1:200,000 epinephrine immediately after the operation)
Trial: 1773780
Drug: PHT 1,000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PHT 1,000 mg
Trial: 1773780
Drug: CBZ 200
RxNorm normalized name: CBZ
DrugBank: Carbamazepine (DB00564)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: CBZ 200 mg
Trial: 7102728
Drug: Methylphenidate (active
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methylphenidate (active medication)
Trial: 2567431
Drug: Combined treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined treatment (salbutamol and ipratropium bromide)
Trial: 2567431
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg of salbutamol nebuliser solution in 2 ml of saline
Trial: 31880966
Drug: Bevacizumab 15
RxNorm normalized name: Bevacizumab
DrugBank: Bevacizumab (DB00112)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Bevacizumab 15 mg/kg
Trial: 28493891
Drug: AIDSVAX® B/E
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AIDSVAX® B/E vaccine
Trial: 22128728
Drug: 150 mg
RxNorm normalized name: pectin 150 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 150 mg dose of armodafinil
Trial: 15259284
Drug: 1 mg
RxNorm normalized name: biotin 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg of estradiol valerate (E2V) plus 2.5 mg of medroxyprogesterone acetate (MPA)
Trial: 10914173
Drug: Continued low-dose
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Continued low-dose aspirin
Trial: 10914173
Drug: Stopped low-dose
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Stopped low-dose aspirin
Trial: 28193214
Drug: Routine delivery
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Routine delivery of oral anticancer therapy
Trial: 25909473
Drug: Blueberry supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Blueberry supplementation (2 cups of frozen blueberries daily for 6 weeks)
Trial: 25437150
Drug: Internet-based cognitive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Internet-based cognitive behavior therapy (ICBT) for 12 weeks
Trial: 21851929
Drug: Internet-based cognitive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Internet-based cognitive behavior therapy (ICBT)
Trial: 17639992
Drug: Xinmaitong capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Xinmaitong capsule (XMT)
Trial: 23810027
Drug: Quality improvement
RxNorm normalized name: tetracaine
DrugBank: Tetracaine (DB09085)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Quality improvement intervention for prescribing antihypertensive medication
Trial: 21091792
Drug: Test implant
RxNorm normalized name: mumps skin test antigen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Test implant with a 1.8 mm turned neck (T)
Trial: 21091792
Drug: Control implant
RxNorm normalized name: Drug Implant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control implant with a 2.8 mm turned neck (C)
Trial: 14871913
Drug: CRP levels
RxNorm normalized name: peanut allergenic extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CRP levels at or above the 90th percentile (10.6 mg/L)
Trial: 11798886
Drug: Methimazole plus
RxNorm normalized name: Methimazole
DrugBank: Methimazole (DB00763)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methimazole plus L‐T(4) 50 microgram/d (Group A)
Trial: 11798886
Drug: Methimazole in
RxNorm normalized name: methimazole Injectable Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methimazole in small dose only (Group B)
Trial: 7799828
Drug: Premarin cream
DrugBank: Conjugated estrogens (DB00286)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Premarin cream (0.625 mg conjugated oestrogens per gram of cream)
Trial: 7799828
Drug: Premarin cream
DrugBank: Conjugated estrogens (DB00286)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Premarin cream
Trial: 2838151
Drug: Single-dose dactinomycin
RxNorm normalized name: Dactinomycin
DrugBank: Dactinomycin (DB00970)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Single-dose dactinomycin (45 micrograms/kg)
Trial: 2838151
Drug: Other hepatotoxic
RxNorm normalized name: Ether
DrugBank: Diethyl ether (DB13598)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Other hepatotoxic agents
Trial: 28398597
Drug: Ozanimod (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ozanimod (1 mg/d and 1.5 mg/d for 28 days)
Trial: 28398597
Drug: Ozanimod (first
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ozanimod (first dose)
Trial: 28398597
Drug: Ozanimod (dose-escalation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ozanimod (dose-escalation regimen)
Trial: 12353708
Drug: Rice starch
RxNorm normalized name: Rice Starch
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rice starch added to bath water (twice daily for 15 min)
Trial: 345484
Drug: Neurolept analgesia
RxNorm normalized name: Analgesic Balm GRX
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neurolept analgesia with topical anaesthesia
Trial: 345484
Drug: Anticholinergic and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anticholinergic and topical anaesthesia with diazepam
Trial: 27117505
Drug: Best conservative
RxNorm normalized name: calcium polycarbophil
DrugBank: Calcium polycarbophil (DB14684)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Best conservative care (personalised hip therapy)
Trial: 18693478
Drug: Iron-fortified rice
RxNorm normalized name: Rice
DrugBank: Rice (DB10563)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iron-fortified rice (daily portion of cooked rice 5 days per week for 6 months)
Trial: 10488999
Drug: H-wave therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: H-wave therapy (HWT)
Trial: 6151741
Drug: Bopindolol 1
RxNorm normalized name: bopindolol 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bopindolol 1 mg
Trial: 2439815
Drug: Bopindolol 2
RxNorm normalized name: bopindolol
DrugBank: Bopindolol (DB08807)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bopindolol 2 mg
Trial: 8335427
Drug: benazepril p.m.
FDA approved: no
EMA approved: no
PMDA approved: no
Description: benazepril p.m. (10 mg)
Trial: 28627862
Drug: Wearable devices
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Wearable devices for upper limb rehabilitation (15 daily sessions at least three times a week for 5 weeks)
Trial: 24796057
Drug: Patient controlled
RxNorm normalized name: PATIENT CONTROLLED ANALGESIA VIAL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Patient controlled intravenous analgesia (analgesia-pumper group)
Trial: 20403941
Drug: Alcohol beverage
RxNorm normalized name: Alcohol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Alcohol beverage (0.4 g/kg)
Trial: 18256140
Drug: Aspirin 75
RxNorm normalized name: aspirin 75 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin 75 mg/day (26-h delay)
Trial: 24636266
Drug: Procalcitonin-guided antibiotic
RxNorm normalized name: Procalcitonin
DrugBank: Procalcitonin (DB14812)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Procalcitonin-guided antibiotic therapy
Trial: 28721080
Drug: Standard antibiotic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard antibiotic therapy
Trial: 9609801
Drug: Microgravity (0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Microgravity (0 G head‐to‐foot acceleration)
Trial: 7928150
Drug: Breast conserving
RxNorm normalized name: chicken breast preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Breast conserving treatment (BCT)
Trial: 7928150
Drug: Wide resection
RxNorm normalized name: salicylic acid
DrugBank: Salicylic acid (DB00936)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Wide resection with a small dose of radiation
Trial: 11449182
Drug: Transdermal estradiol
RxNorm normalized name: estradiol Transdermal System
DrugBank: Estradiol (DB00783)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Transdermal estradiol therapy (TTS) 50 mg/day for 6 months
Trial: 19853678
Drug: Risedronate, 35
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Risedronate, 35 mg once weekly (RIS)
Trial: 17697972
Drug: BU4 (0.8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BU4 (0.8 mg/kg, over 2 hours 4 times a day)
Trial: 7778464
Drug: 6% carbohydrate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 6% carbohydrate solution (CHO)
Trial: 104342
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg of oral amphetamine sulfate
Trial: 104342
Drug: 25 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 25 mg of oral anileridine dihydrochloride
Trial: 104342
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of amphetamine and anileridine
Trial: 28814143
Drug: Spironolactone 25
RxNorm normalized name: spironolactone 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Spironolactone 25 mg/d
Trial: 19421321
Drug: Glutamine (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glutamine (0.5 g/kg/d)
Trial: 3064191
Drug: Combined modality
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined modality treatment (radiotherapy and chemotherapy)
Trial: 26674253
Drug: Dark chocolate
RxNorm normalized name: Ensure Original Dark Chocolate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dark chocolate (DC) 40 g daily